In boost to Amgen, analysts predict osteoporosis market share shift

Change is coming to the osteoporosis market. GlobalData analysts have tipped the market to shift from bisphosphonates to anabolics, putting Amgen and its rivals in line to capture the additional $7 billion in annual sales that are forecast by 2033.